🇺🇸 FDA
Patent

US 11491231

Peptide-oligonucleotide chimeras (POCs) as programmable biomolecular constructs for the assembly of morphologically-tunable soft materials

granted A61KA61K38/10A61K47/545

Quick answer

US patent 11491231 (Peptide-oligonucleotide chimeras (POCs) as programmable biomolecular constructs for the assembly of morphologically-tunable soft materials) held by Northwestern University expires Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Nov 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K38/10, A61K47/545, A61K47/549, A61K47/555